Cuzdan Coskun, N. Et Al. 2017. Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?. International Journal of Rheumatic Diseases , vol.20, no.12 , 1942-1949.

Cuzdan Coskun, N., Ay, S., Evcik, F. D., & GÖKMEN, D., (2017). Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?. International Journal of Rheumatic Diseases , vol.20, no.12, 1942-1949.

Cuzdan Coskun, Nihan Et Al. "Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?," International Journal of Rheumatic Diseases , vol.20, no.12, 1942-1949, 2017

Cuzdan Coskun, Nihan C. Et Al. "Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?." International Journal of Rheumatic Diseases , vol.20, no.12, pp.1942-1949, 2017

Cuzdan Coskun, N. Et Al. (2017) . "Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?." International Journal of Rheumatic Diseases , vol.20, no.12, pp.1942-1949.

@article{article, author={Nihan Cuzdan Coskun Et Al. }, title={Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?}, journal={International Journal of Rheumatic Diseases}, year=2017, pages={1942-1949} }